Insilico and TaiGen Achieve Milestone in Collaboration: Out-Licensed CKD Anemia Candidate ISM4808 Completes first human enrollment and dosing in Phase I clinical trial – Company Announcement - FT.com The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.

#AIDrugDiscovery #CKDAnemia #ClinicalTrials AI-driven CKD anemia candidate ISM4808 completes first human dosing in Phase I trial, advancing from discovery to clinic rapidly. markets.ft.com/data/announc...